New and future immunomodulatory therapy in type 1 diabetes.
about
Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targetsStem cell therapy to cure type 1 diabetes: from hype to hope.Islet inflammation: a unifying target for diabetes treatment?IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetesThyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis)The Missing Heritability in T1D and Potential New Targets for Prevention.Association of the interleukin-18 -137 C/G, -607 A/C polymorphisms with type 1 diabetes: A meta-analysis.Mesenchymal Stem and Progenitor Cells in Regeneration: Tissue Specificity and Regenerative Potential.Antidiabetic agents: past, present and future.Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.Diabetes and beta cell function: from mechanisms to evaluation and clinical implications.Less is more: the detrimental consequences of immunosuppressive therapy in the treatment of type-1 diabetes.Endocrinology research-reflecting on the past decade and looking to the next.Active Subjects With Autoimmune Type 1 Diabetes Have Better Metabolic Profiles Than Sedentary Controls.Effects of TRPM7/miR-34a Gene Silencing on Spatial Cognitive Function and Hippocampal Neurogenesis in Mice with Type 1 Diabetes Mellitus.
P2860
Q26751244-9A3005F5-D844-46C6-9768-26E982CE4F06Q26823294-6C1FBEDE-A731-4830-ADFE-D43A67C12BE5Q26860847-F178445E-1203-4C10-80B8-3740C66DE3C9Q27303126-36834A4C-0522-4077-9E14-F0D749502E34Q34525298-467DF179-E389-4ABC-8FEA-3FEFF0C0770EQ36825758-573E582E-0493-47C6-B793-EBD86D9306ADQ37565203-09D17E66-378D-44C3-A4B9-8DD516285FC5Q37668908-1AE350BC-14C1-4377-A36D-8AE629510B34Q38089737-484350F4-AD12-4C83-A258-75934D782083Q38135862-62B97FB3-94D7-4D9C-A1EB-F751DF68AC04Q38165184-033BE386-EF4D-45EA-821F-E02B8EB22162Q38385236-E3F5035D-6B98-465E-A46E-28900D0DD7A0Q38605678-094E4996-10F1-44AA-8B21-03B8215745D8Q44137350-FD7554EF-FB72-4F5A-858D-D99D374E6A8CQ50900794-8AE5AA66-AABD-4787-B9FD-78D90019D9CB
P2860
New and future immunomodulatory therapy in type 1 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
New and future immunomodulatory therapy in type 1 diabetes.
@ast
New and future immunomodulatory therapy in type 1 diabetes.
@en
type
label
New and future immunomodulatory therapy in type 1 diabetes.
@ast
New and future immunomodulatory therapy in type 1 diabetes.
@en
prefLabel
New and future immunomodulatory therapy in type 1 diabetes.
@ast
New and future immunomodulatory therapy in type 1 diabetes.
@en
P2093
P2860
P1476
New and future immunomodulatory therapy in type 1 diabetes.
@en
P2093
Frank Waldron-Lynch
James E Tooley
Kevan C Herold
P2860
P304
P356
10.1016/J.MOLMED.2012.01.001
P577
2012-02-17T00:00:00Z